CYB5R2
Basic information
Region (hg38): 11:7665100-7677222
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CYB5R2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 33 | 34 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 33 | 1 | 0 |
Variants in CYB5R2
This is a list of pathogenic ClinVar variants found in the CYB5R2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
11-7665389-C-A | not specified | Uncertain significance (Nov 12, 2024) | ||
11-7665394-C-T | not specified | Uncertain significance (Dec 10, 2024) | ||
11-7665427-G-A | not specified | Uncertain significance (Jun 17, 2024) | ||
11-7665439-G-C | not specified | Uncertain significance (Oct 06, 2024) | ||
11-7665448-G-C | not specified | Uncertain significance (Aug 11, 2022) | ||
11-7665453-G-A | not specified | Uncertain significance (Sep 16, 2021) | ||
11-7665483-G-A | not specified | Uncertain significance (Oct 06, 2021) | ||
11-7665496-G-C | not specified | Uncertain significance (Feb 13, 2023) | ||
11-7665502-C-G | not specified | Uncertain significance (Nov 25, 2024) | ||
11-7665507-A-T | not specified | Uncertain significance (Dec 31, 2023) | ||
11-7665517-C-T | not specified | Uncertain significance (Sep 14, 2022) | ||
11-7665519-G-A | not specified | Uncertain significance (Nov 30, 2022) | ||
11-7665542-C-G | not specified | Uncertain significance (Sep 22, 2023) | ||
11-7666454-T-C | not specified | Likely benign (Mar 18, 2024) | ||
11-7666493-C-T | not specified | Uncertain significance (Jan 31, 2022) | ||
11-7666507-G-A | not specified | Uncertain significance (Aug 02, 2021) | ||
11-7666528-C-T | not specified | Uncertain significance (Jul 07, 2022) | ||
11-7666532-C-G | not specified | Uncertain significance (May 30, 2024) | ||
11-7667760-T-C | not specified | Uncertain significance (Oct 07, 2024) | ||
11-7667771-T-C | not specified | Uncertain significance (Aug 02, 2023) | ||
11-7668484-C-T | not specified | Uncertain significance (May 22, 2023) | ||
11-7668498-C-T | not specified | Uncertain significance (Nov 08, 2024) | ||
11-7668535-T-C | not specified | Uncertain significance (Mar 17, 2023) | ||
11-7668536-C-G | not specified | Uncertain significance (Oct 08, 2024) | ||
11-7669226-G-A | not specified | Uncertain significance (Apr 06, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CYB5R2 | protein_coding | protein_coding | ENST00000533558 | 8 | 12123 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
6.82e-10 | 0.0736 | 125630 | 0 | 118 | 125748 | 0.000469 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -1.28 | 204 | 159 | 1.29 | 0.00000862 | 1814 |
Missense in Polyphen | 67 | 61.929 | 1.0819 | 733 | ||
Synonymous | -1.83 | 81 | 62.6 | 1.29 | 0.00000377 | 518 |
Loss of Function | -0.0436 | 14 | 13.8 | 1.01 | 6.50e-7 | 169 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000858 | 0.000858 |
Ashkenazi Jewish | 0.0000992 | 0.0000992 |
East Asian | 0.000109 | 0.000109 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.000680 | 0.000677 |
Middle Eastern | 0.000109 | 0.000109 |
South Asian | 0.000654 | 0.000653 |
Other | 0.000326 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: NADH-cytochrome b5 reductases are involved in desaturation and elongation of fatty acids, cholesterol biosynthesis, drug metabolism, and, in erythrocyte, methemoglobin reduction (By similarity). Responsible for NADH-dependent lucigenin chemiluminescence in spermatozoa by reducing both lucigenin and 2-[4-iodophenyl]-3-[4-nitrophenyl]-5-[2,4- disulfophenyl]-2H tetrazolium monosodium salt (WST-1). {ECO:0000250, ECO:0000269|PubMed:15858218}.;
- Pathway
- Amino sugar and nucleotide sugar metabolism - Homo sapiens (human);Oxidation by Cytochrome P450;O2/CO2 exchange in erythrocytes;Transport of small molecules;Erythrocytes take up carbon dioxide and release oxygen
(Consensus)
Recessive Scores
- pRec
- 0.106
Intolerance Scores
- loftool
- 0.250
- rvis_EVS
- 0.73
- rvis_percentile_EVS
- 86.21
Haploinsufficiency Scores
- pHI
- 0.231
- hipred
- N
- hipred_score
- 0.197
- ghis
- 0.435
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.474
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Cyb5r2
- Phenotype
Gene ontology
- Biological process
- bicarbonate transport;sterol biosynthetic process;oxidation-reduction process
- Cellular component
- nucleus;endoplasmic reticulum membrane;membrane
- Molecular function
- cytochrome-b5 reductase activity, acting on NAD(P)H;protein binding;FAD binding